Investigating multiple tumor types, we found that CLPTM1L was present in the extracellular vesicle fractions culture media from Panc1 pancreatic and cisplatin resistant variants of ovarian tumor cells (Figs. 3e and 4a and Supplementary Fig. 6). Here, CLPTM1L is linked to ovarian neoplasm.